Litcius/Paper detail

Pegylated liposomal encapsulation improves the antitumor efficacy of combretastatin A4 in murine 4T1 triple-negative breast cancer model

Farshad Mirzavi, Mehdi Barati, Roghayyeh Vakili‐Ghartavol, Mostafa Karimi Roshan, Mohammad Mashreghi, Mohammad Soukhtanloo, Mahmoud Reza Jaafari

2021International Journal of Pharmaceutics43 citationsDOI

Topics & Concepts

In vivoLiposomeChemistryTriple-negative breast cancerBioavailabilitySonicationPaclitaxelZeta potentialPharmacologyDispersityBreast cancerCancer researchMaterials scienceNanotechnologyBiochemistryNanoparticleMedicineChemotherapyCancerBiologyChromatographyInternal medicineOrganic chemistryBiotechnologyNanoparticle-Based Drug DeliveryCancer, Lipids, and MetabolismProtease and Inhibitor Mechanisms
Pegylated liposomal encapsulation improves the antitumor efficacy of combretastatin A4 in murine 4T1 triple-negative breast cancer model | Litcius